Thailand Cannabis License 2026: New Regulation No. 2 Explained

Why the 30 April 2026 Reform Matters

The 2569 amendment does not legalize anything new and it does not recriminalize cannabis flower. Instead, it tightens the governance shell around an asset class that the original 2022 framework was never engineered to handle. Cannabis flower remains a “controlled herb,” but Thailand has now stacked extra requirements on every commercial license that touches it — sale, processing, study, research, and export — while leaving the older controlled-herbs regime untouched for traditional botanicals like kwao krua.

The political signal is unambiguous. The Ministry of Public Health is steering the sector toward a closed, medical-grade supply chain in which only credentialed actors handle flower. Operators who built their business on a simple controlled-herbs sales license, with no medical, pharmaceutical, herbal-product, or traditional-healer credential underneath, are the most exposed.

What Counts as a Lawful Premises in 2026

Under the new framework, the regulator only entertains cannabis-flower license applications when the proposed premises fall within a narrow list of qualifying establishments. In practical terms, that means a medical facility, a pharmacy, a registered herbal-product retailer, or the recognized workplace of a traditional Thai medicine practitioner. The freestanding “weed café” or pure retail dispensary, with no underlying healthcare or herbal-product authorization, no longer fits the model the Ministry of Public Health is willing to license.

Applicants must additionally demonstrate lawful possession of the premises — ownership documents, a registered lease, or a written consent from the title-holder — and the address shown on the license must match the one shown on the underlying healthcare or herbal-product authorization. Any inconsistency between the cannabis license, the lease, and the supporting credential is now grounds for deferral or refusal.

Personnel On-Site at All Operating Hours

Operators must staff each licensed location with at least one qualified person whenever the premises is open to the public. Acceptable credentials include a licensed pharmacist, a licensed physician, a registered traditional Thai medicine practitioner, or a worker who has completed the official cannabis-handling training delivered by the Department of Thai Traditional and Alternative Medicine. The on-duty rule is a meaningful capital expense for small operators because it converts an ad-hoc retail role into a regulated full-time position.

Foreign Ownership: Where the Foreign Business Act Bites

Foreign investors entering this sector should treat ownership planning as a separate workstream from cannabis licensing itself. Most cannabis-related commercial activity — retail of controlled herbs, processing, and many service models — is treated as a restricted business under the Foreign Business Act framework Lex Bangkok analyzed earlier this year. That means majority foreign ownership is not available off the shelf; structuring options are limited to a Foreign Business License, a BOI promotion (where the activity qualifies), or a compliant Thai-majority structure that withstands scrutiny.

Crucially, the Department of Business Development is independently tightening the screws on nominee arrangements. Pairing a non-compliant ownership structure with a cannabis license invites two enforcement risks at once. Investors who relied on legacy 51/49 setups should review documentation, source-of-funds evidence, and director arrangements against the latest DBD nominee verification standards before any renewal application.

Sale, Processing, and Export Licenses: What Changed in Substance

The 2569 amendment touches every commercial license category the Ministry issues for controlled herbs that include cannabis flower.

Sale Licenses

Retail and wholesale licenses for cannabis flower now require the supporting healthcare or herbal-product credential at the same address as the proposed sales point, plus the qualified personnel rule above. Walk-in retail with no medical or herbal-product authorization underneath is functionally outside the framework. Operators who hold a 2559-era license that was issued without these conditions retain their permit until its original expiry date but must meet the new criteria at renewal.

Processing Licenses

Processors face stricter facility specifications, source-tracing duties for incoming flower, and tightened standards on labeling, batch records, and outgoing product documentation. Extracts crossing the 0.2% THC threshold continue to be regulated as narcotics under the separate Narcotic Act regime, which means processors targeting high-THC products require a different licensing track entirely.

Export Licenses

Exporters must show the destination market’s import permit and demonstrate that the buyer is authorized to receive cannabis flower under that jurisdiction’s rules. This is consistent with Thailand’s strategic positioning of cannabis flower as a medical input rather than a recreational commodity, and it disqualifies any business model that ships to consumers or non-licensed wholesalers in destination markets.

Practical Compliance Roadmap for International Operators

Foreign-backed operators should treat the next twelve months as a structured remediation window rather than a wait-and-see period. The license expiry calendar drives everything: any operator whose 2559 license expires between now and the end of 2027 will be assessed under the 2569 standards at renewal, and waiting until the renewal window opens is too late.

A defensible work plan covers four parallel tracks. First, premises — confirm whether the site qualifies as a medical facility, pharmacy, herbal-product retailer, or traditional-medicine workplace, and secure the supporting authorization at the same address. Second, personnel — identify and contract the required pharmacist, physician, traditional Thai medicine practitioner, or trained on-duty worker, and budget for the cost of full-time coverage. Third, ownership — revisit the corporate structure against current Foreign Business Act and DBD nominee standards, and, where eligible, evaluate BOI promotion routes. Fourth, recordkeeping — upgrade inventory, prescription, and batch records to a standard that will survive an inspection.

Litigation, Enforcement, and Reputational Exposure

The Ministry has paired the 2569 amendment with sharper enforcement. Inspections now focus on three high-leverage targets: premises mismatches between the cannabis license and the underlying authorization, the absence of a qualified person during operating hours, and missing or backdated batch and prescription records. Each of these is administratively easy for an inspector to verify and difficult for an operator to remediate after the fact.

Beyond administrative penalties, criminal exposure follows the usual Thai pattern: directors and authorized representatives can be implicated personally where the corporate license is used to facilitate unlicensed activity. Foreign directors, in particular, should ensure that signing authority, banking, and operational decisions sit with parties who can be physically present in Thailand and who have not relied on nominee paperwork.

How Lex Bangkok Supports International Cannabis Operators

Lex Bangkok advises international investors, established operators, and new entrants on the full stack of issues triggered by the 2569 amendment — premises classification, foreign ownership structuring, BOI eligibility, license applications and renewals, employment of qualified personnel, and dispute response when a license is refused or suspended. Our team coordinates with healthcare-credentialing professionals so that the cannabis license, the underlying authorization, and the corporate structure are filed as a single coherent package rather than three disconnected applications. For investors expanding into Thailand from regulated foreign markets, we also provide cross-border counsel on import permits, destination-market obligations, and tax structuring under Thailand’s BOI investment promotion framework.

Frequently Asked Questions

Conclusion: A Tighter Market, but a Real One

Thailand has not closed its cannabis sector — it has professionalized it. Operators who can credibly slot into the medical-grade supply chain, with qualified personnel, compliant premises, and an ownership structure that survives Foreign Business Act and DBD review, will find a more durable market than the one that boomed in 2022. Operators who cannot will find that the renewal window doubles as the exit door. International investors who plan their compliance posture early, and who engage Thai counsel before the renewal calendar tightens, retain meaningful optionality in a sector that now rewards substance over speed.